title: Postnatal ontogeny of intestinal GCPII and the RFC in pig.
abstract: In humans and pigs, hydrolysis of dietary polyglutamyl folates is carried out by intestinal brush border folate hydrolase [glutamate carboxypeptidase II (GCPII)], whereas the transport of the monoglutamyl folate derivatives occurs via the intestinal brush border reduced folate carrier (RFC). The study objective was to measure the expression of intestinal GCPII and RFC during postnatal development of pigs and their effects on plasma and liver folate concentrations. Duodenum, jejunum, ileum, liver, and plasma samples were collected from female Yorkshire pigs at birth, 24 h, 1 wk, 3 wk, and 6 mo (n=6 at each time point). GCPII mRNA transcripts and protein (normalized using beta-actin), and enzyme activity (normalized per mg mucosal protein) were highest in all segments of small intestine at birth and were undetectable in ileum after 1 wk, whereas jejunal protein and activity predominated at 6 mo. RFC mRNA transcripts were present in all segments of small intestine at birth and declined significantly throughout development to 6 mo. Conversely, RFC protein increased twofold during the first 24 h and remained constant throughout development in all segments of small intestine. Liver RFC mRNA transcripts were detected at birth but were reduced by 6 mo. Liver folate concentration increased throughout postnatal development, whereas plasma folate levels increased during the first 24 h but decreased over time, reflecting the pattern of RFC expression in small intestine. These findings show that intestinal GCPII and intestinal and hepatic RFC all exhibit ontogenic changes in the pig that are reflected in postnatal folate status.
authors.affiliation: Department of Internal Medicine, University of California, Davis, CA, USA. tshafizadeh@tethysbio.com
authors.forename: Tracy B
authors.initials: TB
authors.lastname: Shafizadeh
authors.forename: Charles H
authors.initials: CH
authors.lastname: Halsted
mesh_terms: D000818:Animals; D004386:Duodenum / Q000201:enzymology / Q000254:growth & development; D005260:Female; D005492:Folic Acid / Q000097:blood; D018507:Gene Expression Regulation, Developmental; D015971:Gene Expression Regulation, Enzymologic; D043425:Glutamate Carboxypeptidase II / Q000235:genetics* / Q000378:metabolism*; D007082:Ileum / Q000201:enzymology / Q000254:growth & development; D007413:Intestinal Mucosa / Q000201:enzymology / Q000254:growth & development; D007421:Intestine, Small / Q000201:enzymology* / Q000254:growth & development*; D007583:Jejunum / Q000201:enzymology / Q000254:growth & development; D008099:Liver / Q000201:enzymology; D026901:Membrane Transport Proteins / Q000235:genetics* / Q000378:metabolism*; D008871:Microvilli / Q000201:enzymology; D012333:RNA, Messenger / Q000378:metabolism; D058978:Reduced Folate Carrier Protein; D034421:Sus scrofa
chemical_list: D026901:Membrane Transport Proteins; D012333:RNA, Messenger; D058978:Reduced Folate Carrier Protein; C548699:SLC19A1 protein, human; D005492:Folic Acid; D043425:Glutamate Carboxypeptidase II